期刊文献+

尾加压素Ⅱ基因多态性与多囊卵巢综合征相关性的研究 被引量:2

Association of genetic variants in urotensin II gene with polycystic ovary syndrome
原文传递
导出
摘要 目的探讨尾加压素Ⅱ(UTS2)基因多态性与多囊卵巢综合征(PCOS)发病的关系。方法用熔解温度不同的基因分型法,检测PCOS患者101例(PCOS组)及其父母202名和105名健康妇女(对照组)UTS2基因rs228648、rs2890565位点单核苷酸多态性(SNP),并检测基础状态下FSH、LH、睾酮、空腹血糖、空腹胰岛素水平。结果PCOS组的UTS2基因rs228648A/G多态性位点与对照组比较,基因型与等位基因频率均无明显差异,两组的SNPrs2890565基因型频率差异有统计学意义(P〈0.05),PCOS组A等位基因频率明显高于对照组(P〈0.05)。传递不平衡检验(TDT)显示,SNPrs228648A/G在杂合子父母的2个不同等位基因无优势传递(P〉0.05),而rs2890565A/G在杂合子父母A等位基因优势传递(P〈0.05)。PCOS组UTS2基因SNPrs228648GG基因型较携带A等位基因的PCOS患者稳态模型评估的胰岛素抵抗指数(HOMA—IR)明显增高(P〈0.05)。SNPrs2890565AA和AG基因型空腹血糖、空腹胰岛素较GG基因型明显增高,AA基因型HOMA—IR较GG基因型明显增高(P〈0.05)。结论UTS2基因SNPrs228648A/G多态性与PCOS无相关性,但与胰岛素抵抗存在关联。UTS2基因SNPrs2890565可能在PCOS的遗传易感性中起一定作用,A等位基因可能与PCOS的发生有关。 Objective To investigate the correlation of single nueleotide polymorphisms (SNP) of rs228648 and rs2890565 in urotensin 11 (UTS2)gene with polycystie ovary syndrome(PCOS). Methods The genotypes of two SNPs in UTS2 gene were determined through polymerase chain reaction Tm-shift genotyping method. 101 Chinese Han families trios in Shandong Province consisting of fathers, mothers, and affected daughters with PCOS and 105 healthy women were recruited. The physiological and biochemical parameters including serum follicular stimulating hormone(FSH) ,luteinizing hormone(LH), testosterone,fasting plasma glucose, and insulin were also measured. Results The distributions of three genotypes and two alleles of SNP rs228648 in UTS2 gene were similar between PCOS group and control group. The distributions of genotypes of SNP rs2890565 in UTS2 gene differed significantly between PCOS group and control group (P 〈 0. 05 ). The frequency of A allele of SNP rs2890565 in UTS2 gene was significantly higher in PCOS group than that in control group( P〈0.05 ). Transmission disequilibrium test(TDT)did not show significantly biased transmission of two different alleles from parents to affected daughters at rs228648 locus (P〉0.05), but showed an excess transmission of A allele from heterozygous parents to affected offspring at rs2890565 locus(P〈0.05). The carriers with GG genotype of SNP rs22864g had significantly higher HOMA-IR compared to those with AA and AG genotypes. The carriers with AA or AG genotype of SNP rs2890565 had significantly higher fasting plasma glucose and fasting insulin compared to those with GG genotypes. HOMA-IR in cases with AA genotype was significantly higher than that with GG genotype. Conclusions There is no association of SNP rs228648 with PCOS, but exists association with insulin resistance. The genetic polymorphism of UTS2 gene rs2890565 may be associated with PCOS, and the higher frequency of A allele is likely to contribute to PCOS.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2010年第5期364-367,共4页 Chinese Journal of Endocrinology and Metabolism
基金 国家重点基础研究发展计划973项目(2007CB948103)
关键词 多囊卵巢综合征 胰岛素抵抗 尾加压素 多态性 单核苷酸 Polycystic ovary syndrome Insulin resistance Urotensin Polymorphism, single nucleotide
  • 相关文献

参考文献13

  • 1祝方,纪立农,罗斌.硬骨鱼紧张素Ⅱ基因多态性与中国人2型糖尿病遗传易感性的关系[J].中华医学杂志,2002,82(21):1473-1475. 被引量:24
  • 2Suzuki S,Wenyi Z,Hirai M,et al.Genetic variations at urotensin Ⅱ and urotensin Ⅱ receptor genes and risk of type 2 diabetes mellitus in Japanese.Peptides,2004,25:1803-1808.
  • 3陈子江,石玉华,赵跃然,李媛,唐蓉,赵力新,张中和.胰岛素受体基因多态性与多囊卵巢综合征发病的关系[J].中华妇产科杂志,2004,39(9):582-585. 被引量:30
  • 4de Paula Martins W,Santana LF,Nastri CO,et al.Agreement among insulin sensitivity indexes on the diagnosis of insulin resistance in polycystic ovary syndrome and ovulatory women.Eur J Obstet Cynecol Reprod Biol,2007,133:203-207.
  • 5Wang J,Chuang K,Ahluealia M,et al.High-throughput SNP genotyping by single-tube PCR with Tm-shift primers.Biotechniques,2005,39:885-893.
  • 6Papp AC,Pinsonneault JK,Cooke G,et al.Single nucleiotide polymorphism genotyping using allele-specific PCR and fluorescence melting curves.Biotechniques,2003,34:1068-1072.
  • 7Elshourbagy NA,Douglas SA,Shabon U,et al.Molecular and pharmacological characterization of genes encoding urotensin Ⅱpeptides and their cognate G-protein-coupled receptors from the mouseand monkey.Br J Pharmacol,2002,136:9-22.
  • 8Wenyi Z,Suzuki S,Hirai M,et al.Role of urotensin Ⅱ gene in genetic susceptibility to Type 2 diabetes mellitus in Japanese subjects.Diabetologia,2003,46:972-976.
  • 9Ong KL,Wong LY,Bun YB,et al.Haplotypes in the urotension Ⅱ gene and urotension Ⅱ receptor gene are associated with insulin resistance and impaired glucose tolerance.Peptides,2006,27:1659-1667.
  • 10Thanassoulis G,Huyhn T,Giaid A.Urotensin Ⅱ and cardiovascular diseases.Peptides,2004,25:1789-1794.

二级参考文献13

  • 1Patel K,Coffler MS,Dahan MH,et al.Relationship of GnRH-stimulated LH release to episodic LH secretion and baseline endocrine-metabolic measures in women with polycystic ovary syndrome.Clin Endocrinol (Oxf),2004,60:67-74.
  • 2Asuncion M,Calvo RM,San Millan JL,et al.A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain.J Clin Endocrinol Metab,2000,85:2434-2438.
  • 3Bernard L,Christin-Maitre S,Basille C,et al.Insulin resistance and polycystic ovary syndrome.Gynecol Obstet Fertil,2003,31:109-116.
  • 4Diamanti-Kandarakis E,Kandarakis HA.Conservative management of gynecologic diseases: insulin sensitizing agents in polycystic ovary syndrome.Ann N Y Acad Sci,2003,997:322-329.
  • 5Dunaif A,Thomas A.Current concepts in the polycystic ovary syndrome.Annu Rev Med,2001,52:401-419.
  • 6Siegel S,Futterweit W,Davies TF,et al.A C/T single nucleotide polymorphism at the tyrosine kinase domain of the insulin receptor gene is associated with polycystic ovary syndrome.Fertil Steril,2002,78:1240-1243.
  • 7The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group.Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).Hum Reprod,2004,19:41-47.
  • 8Barontini M,Garcia-Rudaz MC,Veldhuis JD.Mechanisms of hypothalamic-pituitary-gonadal disruption in polycystic ovarian syndrome.Arch Med Res,2001,32:544-552.
  • 9VrbIkova J,Cibula D,Dvorakova K,et al.Insulin sensitivity in women with polycystic ovary syndrome.J Clin Endocrinol Metab,2004,89:2942-2945.
  • 10Vanky E,Kjotrod S,Salvesen KA,et al.Clinical,biochemical and ultrasonographic characteristics of Scandinavian women with PCOS.Acta Obstet Gynecol Scand,2004,83: 482-486.

共引文献52

同被引文献21

  • 1Stein IF,Leventhal ML.Amenonhea associated with bilateral polycystic ovaries.Am J Obstet Gynecol,1935,29:181-191.
  • 2Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group.Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).Hum Reprod,2004,19:41-47.
  • 3Ehrmann D,Liljenquist D,Kasza K,et al.Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome.J Clin Endocrinol Metab.2006,91:48-53.
  • 4Azziz R,Ehrmann D,Legro RS,et al.Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome:a multicenter,double blind,placebo-controlled trial.J Clin Endocrinol Metab,2001,86:1626-1632.
  • 5Ehrmann DA,Barnes RB,Rosenfield RL,et al.Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.Diabetes Care,1999,22:141-146.
  • 6Zhang YF,Yang YS,Hong J,et al.Elevated serum levels of interleukin-18 are associated with insulin resistance in women with polycystic ovary syndrome.Endocrine,2006,29:419-423.
  • 7Solomon CG,Hu FB,Dunaif A,et al.Menstrual cycle irregularity and risk for future cardiovascular disease.J Clin Endocrinol Metab,2002,87:2013-2017.
  • 8茅江峰(译者),伍学焱(审校者).述评:多囊罗日巢综合征、生物标志和二甲双胍:研究、风险及现状[J].中华内分泌代谢杂志,2008,24(3):325-326. 被引量:8
  • 9吴玉文,张木勋,张建华,王宏伟,温宇,Katherine Cianflone.多囊卵巢综合征患者血浆酰化刺激蛋白水平变化与血脂相关性研究[J].中华内分泌代谢杂志,2008,24(5):513-516. 被引量:4
  • 10彭幼玲,林芸,闻安民.多囊卵巢综合征合并代谢综合征患者的临床特点[J].南方医科大学学报,2008,28(10):1846-1847. 被引量:3

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部